mRNA |
erlotinib:PLX-4032 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.093 |
0.02 |
mRNA |
ML334 diastereomer |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.02 |
mRNA |
BRD-K27188169:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.02 |
mRNA |
Cerulenin |
CTRPv2 |
pan-cancer |
AAC |
0.079 |
0.02 |
mRNA |
PDMP |
CTRPv2 |
pan-cancer |
AAC |
-0.089 |
0.02 |
mRNA |
Bax channel blocker |
CTRPv2 |
pan-cancer |
AAC |
0.091 |
0.02 |
mRNA |
PRL-3 Inhibitor I |
CTRPv2 |
pan-cancer |
AAC |
-0.089 |
0.02 |
mRNA |
VNLG/124 |
GDSC1000 |
pan-cancer |
AAC |
-0.074 |
0.02 |
mRNA |
BMS-754807 |
GDSC1000 |
pan-cancer |
AAC |
-0.076 |
0.02 |
mRNA |
BRD-K48477130 |
CTRPv2 |
pan-cancer |
AAC |
-0.13 |
0.03 |